Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diabetes Detection, Inc. (DDI) was a medical technology company and a subsidiary of Hathaway Corporation (later FutureWorld Corp). Based in St. Petersburg, Florida, the company specialized in developing non-invasive diagnostic tools for the early detection of diabetes-related complications. Its flagship product, the Vibrameter, was a mobile medical device designed to detect diabetic neuropathy and kidney failure by utilizing vibration sensors on communication devices like Blackberries and pagers. DDI aimed to provide a non-invasive, accessible screening method to identify diabetes complications years before clinical diagnosis. Although the company successfully developed a working prototype and entered an alliance with Research In Motion (RIM) in 2006, it did not achieve full commercialization before its parent company underwent restructuring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diabetes Detections.